HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Subscriber Sign In
 
Today@FDA
FDA Calendar
 
Archived Daily Updates
 
FDA Whistleblower
 
What do you think?
Search our 63,616-story database
Search
Renew subscription










E-mail This to a Friend | Print Format  
     
 
FDA Clears Abbott’s Next-gen MitraClip Valve Repair
07/12/2018
 

FDA has approved Abbott’s next-generation MitraClip heart valve repair device used to mend a leaky mitral valve without open-heart surgery. It is designed to “allow for more precise placement during deployment, resulting in more predictable procedures, and additionally offers a second clip size with longer arms that expands the reach of the clip-based device,” the company says. The additional clip size is intended to help physicians treat patients who have more complex anatomies when repairing the mitral valve, it says. MitraClip treats people with degenerative mitral regurgitation, and it is delivered via a catheter to the heart through a blood vessel in the leg.


Post an instant comment on this report here

 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com